{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:50:01Z","timestamp":1793638201794,"version":"4.5.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84401-4","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T18:55:00Z","timestamp":1739472900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Comprehensive pharmacokinetic profiling and molecular docking analysis of natural bioactive compounds targeting oncogenic biomarkers in breast cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Basim","family":"Othman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Beigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Albanghali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmajeed A. A.","family":"Sindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Shanawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Awad Elkarim Mohamed","family":"Ibahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Marghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Kofiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"84401_CR1","doi-asserted-by":"crossref","unstructured":"Alzahrani, S. M., Al Doghaither, H. A., & Al-Ghafari, A. B. General insight into cancer: An overview of colorectal cancer (Review). Mol. Clin. Oncol. 15, 271 (2021).","DOI":"10.3892\/mco.2021.2433"},{"key":"84401_CR2","doi-asserted-by":"publisher","first-page":"20211033","DOI":"10.1259\/bjr.20211033","volume":"95","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson, L. & Gathani, T. Understanding breast cancer as a global health concern. Br. J. Radiol. 95, 20211033 (2022).","journal-title":"Br. J. Radiol."},{"key":"84401_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold, M. et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast 66, 15\u201323 (2022).","journal-title":"Breast"},{"issue":"6","key":"84401_CR4","volume":"15","author":"ZH Kerketta","year":"2023","unstructured":"Kerketta, Z. H., Kujur, A., Kumari, N., Sagar, V. & Pushpa, F. A cross-sectional study on the epidemiology of newly diagnosed breast cancer patients attending tertiary care hospitals in a tribal preponderant state of India: Regression analysis. Cureus 15(6), e40489 (2023).","journal-title":"Cureus"},{"key":"84401_CR5","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/cancers13174287","volume":"13","author":"S \u0141ukasiewicz","year":"2021","unstructured":"\u0141ukasiewicz, S. et al. breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers (Basel) 13, 4287 (2021).","journal-title":"Cancers (Basel)"},{"key":"84401_CR6","first-page":"141","volume":"2","author":"X Wang","year":"2019","unstructured":"Wang, X., Zhang, H. & Chen, X. Drug resistance and combating drug resistance in cancer. Cancer Drug Resist. 2, 141\u2013160 (2019).","journal-title":"Cancer Drug Resist."},{"key":"84401_CR7","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3390\/ph16111615","volume":"16","author":"G Muteeb","year":"2023","unstructured":"Muteeb, G., Rehman, M. T., Shahwan, M. & Aatif, M. Origin of antibiotics and antibiotic resistance, and their impacts on drug development: A narrative review. Pharmaceuticals 16, 1615 (2023).","journal-title":"Pharmaceuticals"},{"key":"84401_CR8","doi-asserted-by":"publisher","first-page":"10663","DOI":"10.3390\/ijms241310663","volume":"24","author":"A Lyubitelev","year":"2023","unstructured":"Lyubitelev, A. & Studitsky, V. Inhibition of cancer development by natural plant polyphenols: Molecular mechanisms. Int. J. Mol. Sci. 24, 10663 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"84401_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/nu8090552","volume":"8","author":"A Niedzwiecki","year":"2016","unstructured":"Niedzwiecki, A., Roomi, M. W., Kalinovsky, T. & Rath, M. Anticancer efficacy of polyphenols and their combinations. Nutrients. 8, 552 (2016).","journal-title":"Nutrients."},{"key":"84401_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/302426","volume":"2013","author":"SY Yin","year":"2013","unstructured":"Yin, S. Y., Wei, W. C., Jian, F. Y. & Yang, N. S. Therapeutic applications of herbal medicines for cancer patients. Evid. Based Complement Altern. Med. 2013, 302426 (2013).","journal-title":"Evid. Based Complement Altern. Med."},{"key":"84401_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3390\/molecules28020887","volume":"28","author":"A Kumar","year":"2023","unstructured":"Kumar, A. et al. Major phytochemicals: Recent advances in health benefits and extraction method. Molecules 28, 887 (2023).","journal-title":"Molecules"},{"key":"84401_CR12","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.3390\/nu15081896","volume":"15","author":"A Rudzinska","year":"2023","unstructured":"Rudzinska, A. et al. Phytochemicals in cancer treatment and cancer prevention-review on epidemiological data and clinical trials. Nutrients 15, 1896 (2023).","journal-title":"Nutrients"},{"key":"84401_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106812","volume":"193","author":"W Liu","year":"2023","unstructured":"Liu, W. et al. Phenolic metabolites as therapeutic in inflammation and neoplasms: Molecular pathways explaining their efficacy. Pharmacol. Res. 193, 106812 (2023).","journal-title":"Pharmacol. Res."},{"issue":"24","key":"84401_CR14","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.3390\/cancers13246222","volume":"13","author":"V Shrihastini","year":"2021","unstructured":"Shrihastini, V. et al. Plant derived bioactive compounds, their anti-cancer effects and in silico approaches as an alternative target treatment strategy for breast cancer: An updated overview. Cancers 13(24), 6222 (2021).","journal-title":"Cancers"},{"key":"84401_CR15","doi-asserted-by":"crossref","unstructured":"Ali, M. et al. Recent advance of herbal medicines in cancer: A molecular approach. Heliyon 9, e13684 (2023).","DOI":"10.1016\/j.heliyon.2023.e13684"},{"key":"84401_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/molecules26041109","volume":"26","author":"CA Dehelean","year":"2021","unstructured":"Dehelean, C. A. et al. Plant-derived anticancer compounds as new perspectives in drug discovery and alternative therapy. Molecules 26, 1109 (2021).","journal-title":"Molecules"},{"key":"84401_CR17","doi-asserted-by":"crossref","unstructured":"Liu, B., Zhou, H., Tan, L., Siu, K. T. H. & Guan, X. Y. Exploring treatment options in cancer: Tumor treatment strategies. Signal Transduct. Target Ther. 9(1), 175 (2024).","DOI":"10.1038\/s41392-024-01856-7"},{"issue":"11","key":"84401_CR18","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/biom13111653","volume":"13","author":"M \u010ci\u017em\u00e1rikov\u00e1","year":"2023","unstructured":"\u010ci\u017em\u00e1rikov\u00e1, M. et al. Ellagic acid and cancer hallmarks: Insights from experimental evidence. Biomolecules 13(11), 1653 (2023).","journal-title":"Biomolecules"},{"issue":"10","key":"84401_CR19","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3390\/nu11102376","volume":"11","author":"A Giordano","year":"2019","unstructured":"Giordano, A. & Tommonaro, G. Curcumin and cancer. Nutrients 11(10), 2376 (2019).","journal-title":"Nutrients"},{"key":"84401_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.975320","volume":"13","author":"M Atteeq","year":"2022","unstructured":"Atteeq, M. Evaluating anticancer properties of Withaferin A-a potent phytochemical. Front. Pharmacol. 13, 975320 (2022).","journal-title":"Front. Pharmacol."},{"key":"84401_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.993775","volume":"12","author":"XD Zhong","year":"2022","unstructured":"Zhong, X. D. et al. Berberine as a potential agent for breast cancer therapy. Front. Oncol. 12, 993775 (2022).","journal-title":"Front. Oncol."},{"issue":"52","key":"84401_CR22","doi-asserted-by":"publisher","first-page":"21243","DOI":"10.1074\/jbc.RA117.000123","volume":"292","author":"RL Edwards","year":"2017","unstructured":"Edwards, R. L. et al. The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites. J. Biol. Chem. 292(52), 21243\u201321252 (2017).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"84401_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12906-017-1555-0","volume":"17","author":"LA BenSaad","year":"2017","unstructured":"BenSaad, L. A., Kim, K. H., Quah, C. C., Kim, W. R. & Shahimi, M. Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum. BMC Complement. Altern. Med. 17(1), 47 (2017).","journal-title":"BMC Complement. Altern. Med."},{"key":"84401_CR24","doi-asserted-by":"crossref","unstructured":"Ansari, P. et al. Pharmacologically active phytomolecules isolated from traditional antidiabetic plants and their therapeutic role for the management of diabetes mellitus. Molecules 27(13), 4278 (2022).","DOI":"10.3390\/molecules27134278"},{"key":"84401_CR25","doi-asserted-by":"crossref","unstructured":"Yip, H. Y. K. & Papa, A. signaling pathways in cancer: Therapeutic targets, combinatorial treatments, and new developments. Cells 10(3), 659 (2021).","DOI":"10.3390\/cells10030659"},{"key":"84401_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116034","volume":"170","author":"MR Islam","year":"2024","unstructured":"Islam, M. R. et al. Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives. Biomed. Pharmacother. 170, 116034 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"84401_CR27","doi-asserted-by":"publisher","first-page":"6238","DOI":"10.3390\/molecules26206238","volume":"26","author":"P Sarbadhikary","year":"2021","unstructured":"Sarbadhikary, P., George, B. P. & Abrahamse, H. Inhibitory role of berberine, an isoquinoline alkaloid, on NLRP3 Inflammasome activation for the treatment of inflammatory diseases. Molecules 26, 6238 (2021).","journal-title":"Molecules"},{"key":"84401_CR28","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1158\/0008-5472.CAN-10-1546","volume":"70","author":"X Zhang","year":"2010","unstructured":"Zhang, X. et al. Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res. 70, 9895\u20139904 (2010).","journal-title":"Cancer Res."},{"key":"84401_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106817","volume":"193","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. Berberine inhibits breast carcinoma proliferation and metastasis under hypoxic microenvironment involving gut microbiota and endogenous metabolites. Pharmacol. Res. 193, 106817 (2023).","journal-title":"Pharmacol. Res."},{"key":"84401_CR30","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3389\/fphar.2019.01461","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Effects of berberine and its derivatives on cancer: A systems pharmacology review. Front. Pharmacol. 10, 1461 (2020).","journal-title":"Front. Pharmacol."},{"key":"84401_CR31","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.apsb.2020.06.014","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5. Acta Pharm Sin. B. 10, 2299\u20132312 (2020).","journal-title":"Acta Pharm Sin. B."},{"key":"84401_CR32","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.3390\/molecules27123661","volume":"27","author":"C Dewi","year":"2022","unstructured":"Dewi, C. et al. Signaling pathways and natural compounds in triple-negative breast cancer cell line. Molecules 27, 3661 (2022).","journal-title":"Molecules"},{"key":"84401_CR33","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.3390\/cancers13143427","volume":"13","author":"R Farghadani","year":"2021","unstructured":"Farghadani, R. & Naidu, R. Curcumin: Modulator of key molecular signaling pathways in hormone-independent breast cancer. Cancers (Basel) 13, 3427 (2021).","journal-title":"Cancers (Basel)"},{"key":"84401_CR34","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/biomedicines9091086","volume":"9","author":"V Zoi","year":"2021","unstructured":"Zoi, V. et al. The role of curcumin in cancer treatment. Biomedicines 9, 1086 (2021).","journal-title":"Biomedicines"},{"key":"84401_CR35","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.3390\/ijms23042144","volume":"23","author":"R Farghadani","year":"2022","unstructured":"Farghadani, R. & Naidu, R. Curcumin as an enhancer of therapeutic efficiency of chemotherapy drugs in breast cancer. Int. J. Mol. Sci. 23, 2144 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"84401_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.675923","volume":"16","author":"S Paul","year":"2021","unstructured":"Paul, S. & Sa, G. Curcumin as an adjuvant to cancer immunotherapy. Front. Oncol. 16(11), 675923 (2021).","journal-title":"Front. Oncol."},{"key":"84401_CR37","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.7150\/ijbs.33710","volume":"15","author":"M Wang","year":"2019","unstructured":"Wang, M. et al. Potential mechanisms of action of curcumin for cancer prevention: Focus on cellular signaling pathways and miRNAs. Int. J. Biol. Sci. 15, 1200\u20131214 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"84401_CR38","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3390\/cancers12051160","volume":"12","author":"AN Sari","year":"2020","unstructured":"Sari, A. N. et al. Combination of Withaferin-A and CAPE provides superior anticancer potency: Bioinformatics and experimental evidence to their molecular targets and mechanism of action. Cancers (Basel) 12, 1160 (2020).","journal-title":"Cancers (Basel)"},{"key":"84401_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.canlet.2012.08.026","volume":"334","author":"ER Hahm","year":"2013","unstructured":"Hahm, E. R. & Singh, S. V. Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression. Cancer Lett. 334, 101\u2013118 (2013).","journal-title":"Cancer Lett."},{"key":"84401_CR40","doi-asserted-by":"crossref","unstructured":"Kumar, S. et al. Withaferin A: A Pleiotropic anticancer agent from the Indian medicinal plant Withania somnifera (L.) Dunal. Pharmaceuticals (Basel) 16, 160 (2023).","DOI":"10.3390\/ph16020160"},{"key":"84401_CR41","doi-asserted-by":"publisher","first-page":"7458","DOI":"10.1002\/fsn3.3699","volume":"11","author":"M Golmohammadi","year":"2023","unstructured":"Golmohammadi, M. et al. A comprehensive review on Ellagic acid in breast cancer treatment: From cellular effects to molecular mechanisms of action. Food Sci. Nutr. 11, 7458\u20137468 (2023).","journal-title":"Food Sci. Nutr."},{"key":"84401_CR42","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.3390\/ijms21103526","volume":"21","author":"M Yousuf","year":"2020","unstructured":"Yousuf, M. et al. Ellagic acid controls cell proliferation and induces apoptosis in breast cancer cells via inhibition of cyclin-dependent kinase 6. Int. J. Mol. Sci. 21, 3526 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"84401_CR43","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/biom13111653","volume":"13","author":"M Cizmarikova","year":"2023","unstructured":"Cizmarikova, M. et al. Ellagic acid and cancer hallmarks: Insights from experimental evidence. Biomolecules 13, 1653 (2023).","journal-title":"Biomolecules"},{"key":"84401_CR44","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein, B. et al. Cancer genome landscapes. Sciences 339, 1546\u20131558 (2013).","journal-title":"Sciences"},{"key":"84401_CR45","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-023-00776-9","volume":"20","author":"MB Lustberg","year":"2023","unstructured":"Lustberg, M. B., Kuderer, N. M., Desai, A., Bergerot, C. & Lyman, G. H. Mitigating long-term and delayed adverse events associated with cancer treatment: Implications for survivorship. Nat. Rev. Clin. Oncol. 20, 527\u2013542 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"84401_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cbi.2006.12.006","volume":"171","author":"IM Kapetanovic","year":"2008","unstructured":"Kapetanovic, I. M. Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach. Chem. Biol. Interact. 171, 165\u2013176 (2008).","journal-title":"Chem. Biol. Interact."},{"key":"84401_CR47","doi-asserted-by":"publisher","first-page":"11942","DOI":"10.1038\/s41598-021-90506-x","volume":"11","author":"KT Hwang","year":"2021","unstructured":"Hwang, K. T. et al. Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer. Sci. Rep. 11, 11942 (2021).","journal-title":"Sci. Rep."},{"key":"84401_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.779786","volume":"12","author":"Q Tan","year":"2022","unstructured":"Tan, Q. et al. Potential predictive and prognostic value of biomarkers related to immune checkpoint inhibitor therapy of triple-negative breast cancer. Front. Oncol. 12, 779786 (2022).","journal-title":"Front. Oncol."},{"key":"84401_CR49","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41417-024-00747-x","volume":"31","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Recent progress of CDK4\/6 inhibitors\u2019 current practice in breast cancer. Cancer Gene Ther. 31, 1283\u20131291 (2024).","journal-title":"Cancer Gene Ther."},{"key":"84401_CR50","volume":"1876","author":"A Servetto","year":"2021","unstructured":"Servetto, A., Formisano, L. & Arteaga, C. L. FGFR signaling and endocrine resistance in breast cancer: Challenges for the clinical development of FGFR inhibitors. Biochim. Biophys. Acta 1876, 188595 (2021).","journal-title":"Biochim. Biophys. Acta"},{"key":"84401_CR51","doi-asserted-by":"publisher","first-page":"8038","DOI":"10.3390\/molecules28248038","volume":"28","author":"M Stielow","year":"2023","unstructured":"Stielow, M. et al. The bioavailability of drugs-the current state of knowledge. Molecules 28, 8038 (2023).","journal-title":"Molecules"},{"key":"84401_CR52","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/nu8110628","volume":"8","author":"AR Pavan","year":"2016","unstructured":"Pavan, A. R. et al. Unraveling the anticancer effect of curcumin and resveratrol. Nutrients 8, 628 (2016).","journal-title":"Nutrients"},{"key":"84401_CR53","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"PC Agu","year":"2023","unstructured":"Agu, P. C. et al. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci. Rep. 13, 13398 (2023).","journal-title":"Sci. Rep."},{"key":"84401_CR54","doi-asserted-by":"publisher","first-page":"6942","DOI":"10.1038\/s41467-022-34574-1","volume":"13","author":"G Fan","year":"2022","unstructured":"Fan, G. et al. Conformational motions and ligand-binding underlying gating and regulation in IP3R channel. Nat. Commun. 13, 6942 (2022).","journal-title":"Nat. Commun."},{"key":"84401_CR55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/ijms17020144","volume":"17","author":"X Du","year":"2016","unstructured":"Du, X. et al. Insights into protein-ligand interactions: Mechanisms, models, and methods. Int. J. Mol Sci. 17, 144 (2016).","journal-title":"Int. J. Mol Sci."},{"key":"84401_CR56","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1042\/EBC20190042","volume":"64","author":"EJ Stollar","year":"2020","unstructured":"Stollar, E. J. & Smith, D. P. Uncovering protein structure. Essays Biochem. 64, 649\u2013680 (2020).","journal-title":"Essays Biochem."},{"issue":"1","key":"84401_CR57","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1038\/s41598-024-54281-9","volume":"14","author":"S Yang","year":"2024","unstructured":"Yang, S. & Kar, S. Protracted molecular dynamics and secondary structure introspection to identify dual-target inhibitors of Nipah virus exerting approved small molecules repurposing. Sci. Rep. 14(1), 3696 (2024).","journal-title":"Sci. Rep."},{"key":"84401_CR58","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.3390\/molecules27185889","volume":"27","author":"SA Almatroodi","year":"2022","unstructured":"Almatroodi, S. A., Alsahli, M. A. & Rahmani, A. H. Berberine: An important emphasis on its anticancer effects through modulation of various cell signaling pathways. Molecules 27, 5889 (2022).","journal-title":"Molecules"},{"key":"84401_CR59","doi-asserted-by":"publisher","first-page":"624494","DOI":"10.3389\/fmolb.2020.624494","volume":"7","author":"M Javed Iqbal","year":"2021","unstructured":"Javed Iqbal, M. et al. Nanotechnology-based strategies for berberine delivery system in cancer treatment: Pulling strings to keep berberine in power. Front. Mol. Biosci. 7, 624494 (2021).","journal-title":"Front. Mol. Biosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84401-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84401-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84401-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T18:57:10Z","timestamp":1739473030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84401-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84401"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84401-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5426"}}